---
edit_url: "https://github.com/dhis2-metadata/HIV_AGG/blob/master/docs/hiv_cs_dashboards_datasets-design.md"
revision_date: '2024-01-14'
tags:
- Implémentation
---

# Tableaux de bord et ensembles de données sur la surveillance des cas { #hiv-cs-dashboards-datasets}

## Tableaux de bord sur la surveillance des cas { #case-surveillance-dashboards } 

Des tableaux de bord thématiques pour le suivi de divers aspects des programmes de soins et de traitement du VIH ont été élaborés sur la base des indicateurs de base inclus dans les [*Lignes directrices unifiées relatives à l'information stratégique sur le VIH centrée sur la personne*](https://www.who.int/publications/i/item/9789240055315) de l'OMS pour l'année 2022. Les visualisations de tableaux de bord standard développées avec les conseils de l'OMS peuvent être rendues au niveau national ou sous-national en fonction de la configuration de l'utilisateur.

Les tableaux de bord sont entièrement alimentés par les *indicateurs* de DHIS2, comme décrit dans la section suivante. Les tableaux de bord suivants sont disponibles pour l'analyse de routine des activités de prévention du VIH.

### [VIH CS - 01. Surveillance des cas](https://demos.dhis2.org/hmis/dhis-web-dashboard/index.html#/vHJr37SQiie) { #hiv-cs-01-case-surveillancehttpsdemosdhis2orghmisdhis-web-dashboardindexhtmlvhjr37sqiie } 

Nombre de nouveaux cas de VIH diagnostiqués pendant l'année en cours, l'année précédente et ceux qui ont commencé un traitement ARV.

![Nouveaux cas de VIH](resources/images/new_hiv_cases.png)

PVVIH de l'année en cours et de la fin de l'année précédente, désagrégées par âge et par sexe

![PVVIH par âge et Sexe](resources/images/plhiv_age_gender.png)

Nouveaux cas de VIH par voie de transmission probable et indicateurs de la PTME

![Voie probable de transmission et PTME](resources/images/route_transmission_pmtct.png)

Nouveaux cas de VIH par groupes clés de la population

![Nouveaux cas de VIH par groupes clés de la population](resources/images/key_population.png)

### [VIH SC - 02. Initiation, maintien et suppression virale de l'ARV](https://demos.dhis2.org/hmis/dhis-web-dashboard/index.html#/wvMQ7MWdBiZ) { #hiv-cs-02-art-initiation-retention-and-viral-suppressionhttpsdemosdhis2orghmisdhis-web-dashboardindexhtmlwvmq7mwdbiz } 

PVVIH sous ARV par mois de l'année en cours et répartition géographique

![PVVIH sous ARV](resources/images/plhiv_art.png)

Accès à l'ARV au moment du diagnostic, dans les 7 jours, et initiation tardive à l'ARV par période et unité d'organisation

![Accès à l'ARV et initiation tardive à l'ARV](resources/images/linkage_art_late_initiation.png)

Rétention du TAR et statut du traitement jusqu'à ce jour

![Rétention du TAR et statut du traitement](resources/images/art_retention_treatment_status.png)

Nombre total d'abandons du TAR par mois et par unité d'organisation

![Nombre total d'abandons du TAR](resources/images/total_attrition_art.png)

Détails des décès liés au SIDA par période et unité d'organisation

![Mortalité due au SIDA](resources/images/aids_mortality.png)

Couverture des tests de charge virale et PVVIH sous TAR avec suppression de la charge virale

![Viral load test coverage and PLHIV with suppressed viral load](resources/images/vl_coverage_suppressedty.png)

Early viral load testing by period and organisation units

![Early viral load testing](resources/images/early_viral_load_testing.png)

### [HIV CS - 03. DSD ART](https://demos.dhis2.org/hmis/dhis-web-dashboard/index.html#/Qy558kJtPLY) { #hiv-cs-03-dsd-arthttpsdemosdhis2orghmisdhis-web-dashboardindexhtmlqy558kjtply } 

Multi-monthly ART dispensing 

![Multi-monthly ART dispensing](resources/images/multi_month_art.png)

DSD ART models eligibility and enrollment 

![DSD ART eligibility and enrollment](resources/images/dsd_eligibility_enrollment.png)

### [HIV CS - 04. HIV/TB](https://demos.dhis2.org/hmis/dhis-web-dashboard/index.html#/hltk73PwPCr) { #hiv-cs-04-hivtbhttpsdemosdhis2orghmisdhis-web-dashboardindexhtmlhltk73pwpcr } 

TPT initiation and completion

![TPT initiation and completion](resources/images/tpt_initiation_completion.png)

TB screening and diagnostic cascade considered priority for high burden HIV/TB settings

![TB screening and diagnostic cascade](resources/images/tb_screening_diagnostic_cascade.png)

### [HIV CS - 05. Epidemic Status](https://demos.dhis2.org/hmis/dhis-web-dashboard/index.html#/JzHjN7ckYQ0) { #hiv-cs-05-epidemic-statushttpsdemosdhis2orghmisdhis-web-dashboardindexhtmljzhjn7ckyq0 } 

Visualisation for the three pilars (3 95%) and their performance during the time

![Three 95 pillars](resources/images/hiv_pillars.png)

### [HIV CS - 06. STI](https://demos.dhis2.org/hmis/dhis-web-dashboard/index.html#/VePGQCvhUBQ) { #hiv-cs-06-stihttpsdemosdhis2orghmisdhis-web-dashboardindexhtmlvepgqcvhubq } 

Syphilis testing and treatment coverage over the time and organisation units

![Syphilis testing coverage](resources/images/syphilis_testing_coverage.png)
![Syphilis test positivity and treatment coverage](resources/images/syphilis_test_positivity_treatment.png)

Gonorrhoea testing and treatment coverage over the time and organisation units

![Gonorrhoea testing coverage](resources/images/gonorrhoea_testing_coverage.png)
![Gonorrhoea test positivity and treatment coverage](resources/images/gonorrhoea_test_positivity_treatment.png)

Presence of STI syndrome and repeat diagnosis of same STI syndrome within 12 months

![STI syndrome](resources/images/sti_syndrome.png)

### [HIV CS - 07. Viral hepatitis](https://demos.dhis2.org/hmis/dhis-web-dashboard/index.html#/vEE54GnKoyq) { #hiv-cs-07-viral-hepatitishttpsdemosdhis2orghmisdhis-web-dashboardindexhtmlvee54gnkoyq } 

HBV test, positivity and treatment coverage by period and organisation units

![HBV](resources/images/hbv.png)

HCV test, positivity, treatment coveragea and cured by period and organisation units

![HCV](resources/images/hcv.png)

### [HIV CS - 08. Cervical cancer](https://demos.dhis2.org/hmis/dhis-web-dashboard/index.html#/pqPcYIVrT5C) { #hiv-cs-08-cervical-cancerhttpsdemosdhis2orghmisdhis-web-dashboardindexhtmlpqpcyivrt5c } 

Cervical cancer screening coverage, outputs and treatment

![Cervical cancer](resources/images/cervical_cancer.png)

## Case surveillance indicators { #case-surveillance-indicators } 

The toolkit contains DHIS2 indicators which represent the core and optional indicators listed in the WHO’s 2022 [Consolidated guidelines on person-centred HIV strategic information](https://www.who.int/publications/i/item/9789240055315). 

All HIV Case Surveillance dashboards are served by DHIS2 indicators, which often combine numerators and denominators from individual-level data or other sources. The DHIS2 indicators are mapped and aligned to the indicator definitions and descriptions contained in the [WHO’s Digital Adaptation Kit (DAK) for HIV, second edition](resources/files/WHO_standard_indicators_cs.xlsx).

Two indicator groups have been configured to group the indicators as follows: 
- HIV Case Surveillance - WHO standard list (hQi48w5BAPp): contains all core WHO SI indicators.
- HIV Case Surveillance - Dashboard (UUipOH5GEN8): contains all indicators that are used in the standard recommended dashboards; these represent a subset of the WHO standard list

## Case Surveillance Data Sets { #case-surveillance-data-sets } 

As described above, dashboards are populated using the aggregate data model, using DHIS2 indicators. Aggregate datasets, data elements and category combinations have been configured to serve the analytics based on the dimensions of analysis included in the strategic information and data use guidelines. When used in tandem with the DHIS2 Case Surveillance Tracker, values from program indicators are mapped to their corresponding aggregate data element and CatCombo in order to populate the numerators and denominators for all the indicators included above. These datasets can also be used for aggregated reporting among sites that do not yet have Tracker; or sites that submit routine reports that aggregate data from another individual level data collection tool. 

Detailed description of the configuration of program indicators for aggregating tracker data is described in the section Program Indicators. Mapping and exchange of Tracker data to Aggregate data model is described in the section Metadata Mapping & Data Exchange. 

There are three (3) distinct datasets for capturing HIV case surveillance data. These have been designed based on the analytical needs represented in the WHO’s analysis framework, whereby some metrics may be analyzed on a monthly basis while others are only reported and analyzed annually:

- HIV Case surveillance - Population estimates (annual)
- HIV case surveillance (yearly)
- HIV case surveillance (monthly)

### HIV Case surveillance - Population estimates { #hiv-case-surveillance-population-estimates } 

HIV Case surveillance - Population estimates
This dataset contains three (3) data elements which are not derived from routine reporting but are typically modeled estimates; and are typically made available by the HIV programme on an annual basis. These data elements are used for populating denominators for core indicators from the strategic information guidelines. The data set should be assigned to the lowest administrative level for which high-quality estimates exist and can be used for analysis. 

These estimates are used for the calculation of the following indicators: 

- HIV CS - ART.1 People living with HIV on ART (Population level) (%)
- HIV CS - VER.2  Early infant diagnosis (EID) coverage (2 months) (%)
- HIV CS - VER.2  Early infant diagnosis (EID) coverage (12months) (%)
- HIV CS - VER.3 Infant ARV prophylaxis coverage (Population level) (%)
- HIV CS - VER.4 ART coverage in pregnant women (Population level) (%)
- HIV CS - INC.1 HIV incidence (/1000 uninfected population) (CS)
- HIV CS - MOR.1 AIDS-related mortality (/100000 population)

![Population Estimation](resources/images/hiv_case_surveillance_pop_estimates.png)

### HIV case surveillance (yearly) { #hiv-case-surveillance-yearly } 

This dataset contains data elements required for annual analysis based on data aggregated from HIV case surveillance service delivery & distribution sites. It includes the following:

- Clients attending HIV case and treatment services by key population category, age and gender
- PLHIV with a multi-monthly drug administration
- PLHIV enrolled and eligible for DSD ART models by age and gender
- PLHIV in DSD ART model tested for viral load and the ones with viral suppression
- Pregnant women on ART delivering at a facility and the ones with a suppressed viral load
- HIV-exposed infant ART prophylaxis status
- HIV-exposed infant HIV and viral load testing
- PLHIV initiating ART screened for TB
- PLHIV initiating ART investigated and diagnosed for TB disease and relative treatment
- PLHIV tested for syphilis and gonorrhoea by key population category
- PLHIV tested for syphilis and gonorrhoea by age and gender
- PLHIV treated for syphilis and gonorrhoea
- PLHIV diagnosed with STI syndromes
- PLHIV tested for viral hepatitis
- PLHIV treated for viral hepatitis and final outcome
- WLHIV screened for cervical precancer lesions and cervical cancer
- WLHIV diagnosed with cervical cancer and relative treatment

### HIV case surveillance (monthly) { #hiv-case-surveillance-monthly } 

This dataset contains data elements for routine monthly analysis based on data aggregated from HIV care and treatment service delivery & distribution sites. It contains the following: 

- New HIV cases by age, gender and key population category 
- ART initiation 
- PLHIV baseline CD4 count at diagnosis
- PLHIV currently on ART
- PLHIV virologically suppressed
- PLHIV on ART for at least six months
- PLHIV in the cohort by age and gender
- Probable route of transmission of new HIV cases
- ART treatment status by gender
- PLHIV with a multi-monthly drug administration
- PLHIV initiating ARTdiagnosed for TB disease and relative treatment
- PLHIV eligible for TB preventive treatment and initiation by age and gender
- TB preventive treatment administered by type
- PLHIV tested for syphilis and gonorrhoea
- Deaths by AIDS-related causes

## Case Surveillance Data Elements { #case-surveillance-data-elements } 

Aggregate domain data elements that are expected to be populated for dashboard analyses are grouped within the Data Element Group ‘HIV case surveillance (dashboard)’ [c6UHfpFrztd]. The data element group allows for easy identification of which data elements should be targeted for exchanging Tracker data to aggregate data elements using the Data Exchange App. 

Some of the data elements contained in the datasets above are cloned (as distinct DEs with distinct DHIS2 IDs) and included in both the monthly and yearly dataset. These cloned metrics are typically counting the number of unique clients within a month or a year; and cannot be aggregated by month to produce the correct number since we are interested in a cohort of clients, not the number of services provided. For example, the same client can access the service multiple times during the year; if we collect this information on a monthly basis and sum across the annual period, we cannot be sure that we did not count the same client multiple times. In these cases, the DEs are clearly labelled with a post-fix as monthly or yearly, as in the example below: 

- HIV - STI: PLHIV tested for syphilis (monthly)
- HIV - STI: PLHIV tested for syphilis (yearly)

